World's Best Scientists 2026 revealed!
Felix K.-H. Chun

Felix K.-H. Chun

D-Index & Metrics

Medicine

D-Index
78
Citations
20039
World Ranking
18127
National Ranking
957

Felix K.-H. Chun publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Felix K.-H. Chun sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 770 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Felix K.-H. Chun D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Felix K.-H. Chun sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Felix K.-H. Chun is affiliated with Universität Hamburg in Germany, with a research focus primarily in the field of Medicine. Their work spans several subfields including Pulmonary and Respiratory Medicine, Surgery, Urology, Oncology, and Molecular Biology.

The scientist's main areas of study concentrate on cancer and urological diseases, particularly:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Urological Disorders and Treatments
  • Renal Cell Carcinoma Treatment
  • Renal and Related Cancers

Felix K.-H. Chun has published extensively in the following venues, which frequently feature their work:

  • Urologic Oncology Seminars and Original Investigations
  • The Journal of Urology
  • Clinical Genitourinary Cancer
  • The Prostate
  • World Journal of Urology

Their recent notable papers include:

  • "Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis," 2022, European Urology Focus
  • "Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer: Updated Network Meta-analysis Stratified by Disease Volume," 2023, European Urology Focus
  • "Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis," 2021, European Urology Focus
  • "Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours," 2024, Nature
  • "Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis," 2021, Prostate Cancer and Prostatic Diseases

Felix K.-H. Chun collaborates regularly with a number of coauthors frequently appearing in their publications. These include:

  • Zhe Tian
  • Fred Saad
  • Pierre I. Karakiewicz
  • Alberto Briganti
  • Derya Tilki

Best Publications

  • Multi-institutional validation of a new renal cancer-specific survival nomogram.

    Pierre I. Karakiewicz;Alberto Briganti;Felix K H Chun;Quoc Dien Trinh

  • Complications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate Cancer

    Alberto Briganti;Felix K.-H. Chun;Andrea Salonia;Nazareno Suardi

  • EVALUATION OF PROSTATE CANCER DETECTION WITH REAL- TIME-ELASTOGRAPHY: A COMPARISON WITH STEP SECTION PATHOLOGICAL ANALYSIS AFTER RADICAL PROSTATECTOMY

    G. Salomon;J. Köllermann;I. Thederan;T. Schlomm

  • High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series

    Jochen Walz;Markus Graefen;Felix K.-H. Chun;Andreas Erbersdobler

  • Validation of a Nomogram Predicting the Probability of Lymph Node Invasion among Patients Undergoing Radical Prostatectomy and an Extended Pelvic Lymphadenectomy

    Alberto Briganti;Felix K.-H. Chun;Felix K.-H. Chun;Andrea Salonia;Giuseppe Zanni

  • Validation of a Nomogram for Prediction of Side Specific Extracapsular Extension at Radical Prostatectomy

    Thomas Steuber;Markus Graefen;Alexander Haese;Andreas Erbersdobler

  • Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.

    Felix K.-H. Chun;Thomas Steuber;Andreas Erbersdobler;Eike Currlin

  • Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram

    Felix K. Chun;Alexandre de la Taille;Hendrik van Poppel;Michael Marberger

  • Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.

    Alberto Briganti;Felix K.-H. Chun;Felix K.-H. Chun;Andrea Salonia;Andrea Gallina

  • Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

    Marco Auprich;Anders Bjartell;Felix K.-H. Chun;Alexandre de la Taille

  • Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study

    Michael Rink;Felix K. Chun;Roland Dahlem;Armin Soave

  • Death Certificates Are Valid for the Determination of Cause of Death in Patients With Upper and Lower Tract Urothelial Carcinoma

    Michael Rink;Michael Rink;Harun Fajkovic;Eugene K. Cha;Amit Gupta

  • Circulating Prostate Tumor Cells Detected by Reverse Transcription-PCR in Men with Localized or Castration-Refractory Prostate Cancer: Concordance with CellSearch Assay and Association with Bone Metastases and with Survival

    Pauliina Helo;Angel M. Cronin;Daniel C. Danila;Sven Wenske

  • Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort

    Atiqullah Aziz;Matthias May;Maximilian Burger;Rein-Jüri Palisaar

  • Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.

    Alberto Briganti;Felix K.-H. Chun;Felix K.-H. Chun;Andrea Salonia;Andrea Gallina

  • Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.

    Andrea Gallina;Felix K H Chun;Felix K H Chun;Nazareno Suardi;James A. Eastham

  • Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging

    Marco Auprich;Felix K.-H. Chun;John F. Ward;Karl Pummer

  • Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions

    Alexandre de la Taille;Jacques Irani;Markus Graefen;Felix Chun

  • Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer.

    Nicole Fischer;Olaf Hellwinkel;Claudia Schulz;Felix K.H. Chun

  • Nomogram Predicting the Probability of Early Recurrence After Radical Prostatectomy for Prostate Cancer

    Jochen Walz;Felix K.-H. Chun;Eric A. Klein;Alwyn Reuther

Frequent Co-Authors

Markus Graefen
Markus Graefen Universität Hamburg
Pierre I. Karakiewicz
Pierre I. Karakiewicz University of Montreal
Hartwig Huland
Hartwig Huland Universität Hamburg
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Thorsten Schlomm
Thorsten Schlomm Charité - University Medicine Berlin
Patrizio Rigatti
Patrizio Rigatti Vita-Salute San Raffaele University
Quoc-Dien Trinh
Quoc-Dien Trinh Brigham and Women's Hospital
Christian Meyer
Christian Meyer Greifswald University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career doesn’t always start with medical school. Many students explore online degrees and certifications that lead to important roles in healthcare. These flexible programs are ideal for those looking to enter the workforce quickly or support their medical studies.

For example, a health information technology online degree prepares graduates for roles in managing medical records and healthcare data. Similarly, learning how much is medical billing and coding school can help you plan for a career in medical billing and coding—crucial for the financial health of clinics and hospitals.

Aspiring nurses often look for most affordable nurse practitioner programs or affordable nursing programs online. These pathways can accelerate your entry into nursing, advance your credentials, and provide a cost-effective option for career growth.

Whether you want to work in medical administration, clinical practice, or patient care, online programs offer flexible, affordable routes to high-demand healthcare professions.

Best Scientists Citing Felix K.-H. Chun

Trending Scientists

Recently Published Articles